Insurance policies can be super different from one person to the next, even within the same company
People taking semaglutide or tirzepatide had significantly lower all-cause mortality and lower risks of stroke and dementia compared with patients using other diabetes medications
Gala Health GLP-1 Review 2026: Compounded GLP-1 Access Is Changing - What to Verify on Pricing, FDA Status, and Refund Terms Before You Enroll How Gala Health's $179/Mo GLP-1/GIP Program, Microdosing Track, No-Insurance Model, and Compounded Medication Disclosures Stack Up for Cash-Pay Weight Loss Seekers in 2026 WILMINGTON, Del., May 5, 2026 (Newswire.com) - Advertorial Disclosure: This article is sponsored advertorial content and may contain affiliate links
Results were similar in various sensitivity analyses, including analyses with additional active comparator (i.e., all other non-insulin agents except SGLT2i), as-treated analyses, and competing risk analyses
Effective and early glycaemic control after diagnosis of T2D and control of other CV risk factors can prevent CV events